On Tuesday, Trevena Inc (NASDAQ:TRVN)’s shares inclined 0.19% to $10.78.
Trevena, Inc. (TRVN), a clinical stage pharmaceutical company focused on the discovery and development of biased ligands targeting G protein coupled receptors (GPCRs), recently declared that the Company will present four posters at PAINWeek®, the National Conference on Pain for Frontline Practitioners, being held at The Cosmopolitan Las Vegas, in Las Vegas, NV from September 8 – 12, 2015. The poster presentations highlight data from the Phase 2a/b trial of TRV130 in postoperative pain following bunionectomy surgery, Phase 1 data for oral TRV734 for acute and chronic pain (2 posters), and preclinical data for TRV250, an oral delta receptor biased ligand in development for the treatment of migraine.
The TRV130 bunionectomy trial abstract was selected for an oral presentation, which will be given by Franck Skobieranda, MD, vice president of clinical development at Trevena, in a session from 7:00 – 7:55 AM PDT on Friday September 11 in Gracia 5.
The posters will be accessible for viewing in Gracia 7 at The Cosmopolitan Las Vegas during the meeting and Dr. Skobieranda and Dr. Michael Lark, Trevena’s chief scientific officer, will be accessible to talk about the posters during the Poster Reception on Thursday, September 10, from 7:00 pm - 9:00 pm PDT.
Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. The companys central nervous system product pipeline comprises TRV130, a small molecule G protein biased ligand at the mu-opioid receptor, which is in Phase II clinical trials for patients experiencing moderate to severe acute pain where IV administration is preferred; and TRV734, a small molecule G protein biased ligand at the mu-opioid receptor that is in Phase I clinical trials for the treatment of moderate to severe acute and chronic pain. Its central nervous system product pipeline also comprises TRV250, a small molecule G protein biased ligand of the delta-opioid receptor, which is in preclinical development stage for the treatment-refractory migraine headaches.
Fortune Brands Home & Security Inc (NYSE:FBHS)’s shares gained 0.4% to $50.75.
From business trips to staff meetings, more than 122 million people are full-time employees, and spend an average of 47 hours a week or more at their workplace.** Adjusting to the work environment; securing valuables; and balancing responsibilities, assignments and deadlines are all important aspects of being in the workforce. Master Lock offers assistful advice and easy-to-use products for securing belongings while in work mode.
“Most people spend a majority of their time at work, which makes it important to take the necessary steps to ensure a safe and secure workplace,” said Rebecca Smith, vice president, marketing for Master Lock. “We want to provide reliable products and tips to assist create a secure work environment.”
Whether starting a first job, transitioning to a new company or simply evaluating the security at a current workplace, Master Lock is providing consumers with tips to assist secure their belongings at the workplace and their homes while they’re on the job.
Secure Spare Keys: With 73 percent of U.S. and Canadian residents working outside of their home,* hiding a spare house key under a mat or rock makes consumers susceptible to possible break-ins and thefts. Provide secure access to cleaning services, maintenance workers, babysitters or a family member with a trusted key lock box, such as the Master Lock 5422D Portable Key Safe, which offers keyless convenience and secure storage of keys and access cards to provide peace of mind when at the office. Be selective when giving out the code, and only provide access to trusted friends, family and workers.
Fortune Brands Home & Security, Inc. provides home and security products for use in residential home repair, remodeling, new construction, security applications, and storage. It operates in four segments: Cabinets, Plumbing, Doors, and Security. The Cabinets segment manufactures custom, semi-custom, and stock cabinetry, in addition to vanities for the kitchen, bath, and other parts of the home under various brand names, counting Aristokraft, Kitchen Craft, Kitchen Classics, Omega, Schrock, Homecrest, Decorá, Diamond, St. Paul, Kemper, Thomasville, and Martha Stewart Living in North America. The Plumbing segment manufactures or assembles, and sells faucets, accessories, and kitchen sinks under the Moen brand name in North America, China, Southeast Asia, and South America.
At the end of Tuesday’s trade, Arthur J. Gallagher & Co. NYSE:AJG)‘s shares surged diped 1.92% to $42.46.
Arthur J. Gallagher & Co. (AJG) recently declared the acquisition of National Administration Company in Chesterfield, Missouri. Terms of the transaction were not revealed.
Founded in 1987, National Administration Company (NAC) is a national program administrator that offers affinity group and association products and services throughout the United States. It specializes in the formation and administration of associations and provides administration services, insurance benefits, and legal, regulatory and compliance standard expertise for its clients. Dale Turvey and his team will continue to operate from their Chesterfield location under the direction of Kevin Garvin, head of Gallagher’s North American affinity operations.
Arthur J. Gallagher & Co., together with its auxiliaries, provides insurance brokerage and risk administration services in the United States and internationally. It operates through three segments: Brokerage, Risk Administration, and Corporate. The Brokerage segment comprises of retail and wholesale brokerage operations. Its retail brokerage operations negotiate and place property/casualty, employer-offered health and welfare insurance, and healthcare exchange retirement solutions for middle-market commercial, industrial, public entity, religious, and not-for-profit entities.
Chemours Co (NYSE:CC), ended its Tuesday’s trading session with 1.73% gain, and closed at $9.12.
The Chemours Company (CC), a global chemical company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, declared financial results for the second quarter 2015. Chemours was a wholly-owned partner of DuPont during the period, and these results reflect a stand-alone basis of presentation.
Second quarter net sales were $1.5 billion, a decrease of 10 percent from $1.7 billion in the preceding-year quarter. Second quarter net loss was $18 million, or a pro forma net loss of $0.10 per diluted share, as compared to net income of $116 million in the second quarter 2014. Adjusted EBITDA was $127 million as compared to $235 million in the preceding year quarter. Profitability was reduced as a result of 11 percent lower-global- average local TiO2 prices, about $48 million from unfavorable currency movements and about $15 million from planned and unplanned plant outages. Lower year-over-year corporate and other operating costs partially offset these impacts.
The Chemours Company, a chemical company, provides titanium technologies, fluoroproducts, and chemical solutions. Its flagship products comprise brands, such as Teflon, Ti-Pure, Krytox Viton, Opteon, and Nafion. The company produces titanium dioxide, with Ti-Pure for coatings, plastics, laminates, and paper; and fluoroproducts, counting Teflon fluoropolymers, Krytox performance lubricants, Viton fluoroelastomers, and Opteon refrigerants.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
